tiprankstipranks
Trending News
More News >
Mangalam Drugs & Organics Ltd. (IN:MANGALAM)
:MANGALAM
India Market

Mangalam Drugs & Organics Ltd. (MANGALAM) Income Statement

Compare
1 Followers

Mangalam Drugs & Organics Ltd. Income Statement

Last quarter (Q1 2026), Mangalam Drugs & Organics Ltd.'s total revenue was ₹572.09M, a decrease of -25.21% from the same quarter last year. In Q1, Mangalam Drugs & Organics Ltd.'s net income was ₹-137.98M. See Mangalam Drugs & Organics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 3.18B₹ 3.67B₹ 3.70B₹ 4.47B₹ 3.80B
Gross Profit
₹ 1.50B₹ 188.12M₹ 287.77M₹ 546.89M₹ 976.69M
Operating Expenses
₹ 1.31B₹ 162.23M₹ 147.74M₹ 193.17M₹ 532.22M
Depreciation and Amortization
₹ 166.07M₹ 146.51M₹ 109.89M₹ 102.49M₹ 91.75M
EBITDA
₹ 363.25M₹ 174.95M₹ 259.54M₹ 451.84M₹ 550.15M
Operating Income
₹ 174.00M₹ 10.62M₹ 150.97M₹ 355.66M₹ 444.47M
Other Income/Expenses
₹ 0.00₹ -121.20M₹ 0.00₹ -78.33M₹ -49.28M
Pretax Income
₹ 47.86M₹ -110.73M₹ 22.14M₹ 277.33M₹ 395.19M
Net Income
₹ 67.21M₹ -90.72M₹ 12.70M₹ 196.57M₹ 279.71M
Per Share Metrics
Basic EPS
₹ 4.25₹ -5.73₹ 0.80₹ 12.42₹ 17.67
Diluted EPS
₹ 4.25₹ -5.73₹ 0.80₹ 12.42₹ 17.67
Weighted Average Shares Outstanding
15.81M 15.83M 15.83M 15.83M 15.83M
Weighted Average Shares Outstanding (Diluted)
15.81M 15.83M 15.83M 15.83M 15.83M
Currency in INR

Mangalam Drugs & Organics Ltd. Earnings and Revenue History